JP Patent

JP5556924B2 — 緑内障の治療又は予防のための医薬組成物

Assigned to Ube Corp · Expires 2014-07-23 · 12y expired

What this patent protects

Patent listed against omidenepag-isopropyl.

Drugs covered by this patent

omidenepag-isopropyl (OMIDENEPAG ISOPROPYL)

Patent Metadata

Patent number: JP5556924B2
Jurisdiction: JP
Classification: —
Expires: 2014-07-23
Drug substance claim: No
Drug product claim: No
Assignee: Ube Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.